News – PoNS – Portable Neuromodulation Stimulator

News

Title

Date

Helius to Highlight Innovative PoNS TherapyTM at the 2023 Consortium of Multiple Sclerosis Centers Annual Meeting, in Commemoration of World MS Day

May 24, 2023
Helius Medical Technologies to Spotlight Expanded Authorizations for its PoNS Device at 2023 American Academy of Neurology Annual Meeting, Booth 1685

Apr 17, 2023
Helius Medical Technologies, Inc. Announces Participation of Neurology Center of New England in its Therapeutic Experience Program

Jan 10, 2023
Helius Extends its Patient Therapy Access Program (PTAP), Bringing the Benefits of its PoNS® Device to More People with Multiple Sclerosis

Jan 05, 2023
Helius Launches UpScript Telehealth e-Commerce Site, Making it Easier for Americans with Multiple Sclerosis to Access Neurotech that can Improve their Ability to Walk

Jan 03, 2023
Helius Medical Technologies, Inc. Announces Participation of Dr. Prue Plummer and MGH Institute of Health Professions to its Therapeutic Experience Program

Nov 10, 2022
Helius Medical Technologies, Inc. Announces Participation of Oregon Health & Science University in its Therapeutic Experience Program

Nov 08, 2022
Helius to Showcase Innovative PoNS Device at ACRM’s 2022 Conference – Demonstrating the Power of Neuromodulation to Help People with MS Improve their Gait

Nov 03, 2022
Helius Salutes Physical Therapists for Their Role in Helping People with MS Improve Their Gait

Oct 13, 2022
Helius Medical Technologies, Inc. Announces Online Training for PoNS Therapy™

Jul 12, 2022
Helius Medical Technologies, Inc. Presents Poster at the 2022 Consortium of Multiple Sclerosis Centers (“CMSC”) Annual Meeting

Jun 06, 2022
Helius Medical Technologies, Inc. Announces Launch of Patient Therapy Access Program for PoNS®

Jun 01, 2022
Helius Medical Announces Poster to Be Presented at the Consortium for Multiple Sclerosis Centers (CMSC) Annual Conference

May 31, 2022
Helius Medical Technologies, Inc. Reports First Quarter 2022 Financial Results and Provides Update on U.S. Commercial Launch of PoNS®

May 12, 2022
Helius Medical Technologies, Inc. Fulfills First U.S. Prescriptions for PoNS®

Apr 27, 2022
Helius Medical Technologies, Inc. Introduces Device in U.S. To Help Multiple Sclerosis Patients Improve Walking Ability

Apr 26, 2022
Helius Medical Technologies, Inc. Announces Issuance of U.S. Patent for Wireless PoNS®

Dec 14, 2021
Helius Medical Technologies, Inc. Launches Therapeutic Experience Program; NYU Langone Health Is Initial Clinical Trial Site

Nov 08, 2021
Helius Medical, Inc. Receives U.S. Marketing Authorization for the PoNS™ Device

Mar 29, 2021
Helius Medical Technologies, Inc. Announces Formation of Multiple Sclerosis Scientific Advisory Board

Oct 08, 2020
Helius Medical Technologies, Inc. Announces FDA Has Granted the PoNS Device Breakthrough Device Designation for the Treatment of Gait Deficits Due to Symptoms of Multiple Sclerosis

May 12, 2020